Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015
MIAMI (PRWEB) April 17, 2015 -- Global Stem Cells Group has announced plans to attend the GTCbio Stem Cell Summit 2015 April 27 - 29, 2015 in Boston. This world-class summit will present the latest developments in all areas of stem cell research including applications, biology, medicine, regulations, and the business of stem cells and regenerative medicine.
The conference will address recent developments in pre-clinical and clinical trials, as well as translational research in stem cell therapies, regenerative medicine, tissue engineering, stem cell reprogramming and regulatory guidance. There will be an additional focus on business opportunities in stem cell medicine and its challenges, and discussions on potential strategies for overcoming these challenges.
The GTCbio Summit includes two parallel conferences with joint sessions on stem cell research in the diabetes space, and stem cell therapies from bench to bedside. Both conferences will also feature a lineup of 34 distinguished speakers from a broad spectrum in the medical community. Keynote speakers for both conferences include Masayo Takahashi, MD, PhD, CDB Ophthalmologist, Center for Developmental Biology; Douglas Melton, PhD, Professor & Investigator, Harvard Medical School, and Rudolf Jaenisch, MD, Professor of Biology, Massachusetts Institute of Technology.
Conference A: The 12th Stem Cell Research & Regenerative Medicine Conference discussion topics include:
• Cells for Therapeutic Development & Drug Discovery
• Advances in Adult & Pluripotent Stem Cells
• Tissue Engineering
• Immunotherapy: Revolution in Cancer Treatments
• Joint Session: Regulatory Challenges in Cell Therapy
Conference B: The 4th Stem Cell Product Development & Commercialization Conference discussion topics include:
• Manufacturing & Product Development
• Challenges in Developing Clinical Efficacy
• Funding Opportunities
• Commercialization: Creating Sustainable Business Models
• Joint Session: Regulatory Challenges in Cell Therapy
The GTCbio Summit 2015 will be held at the Hyatt Regency Boston Hotel. For more information, visit the summit website. To learn more about Global Stem Cells Group, visit the GSCG website, email bnovas(at)stemcellsgroup(dot)com, or call 305-224-1858.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
ABOUT GTCbio:
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002. For more information, visit the GTCBIO website, email infogtcbio(at)gtcbio(dot)com, or call 626) 256-6405.
###
Benito Novas, Global Stem Cells Group, http://www.stemcellsgroup.com, +1 305-224-1858, [email protected]
Share this article